AVXLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
ANAVEX LIFE SCIENCES CORP.
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 28, 2026
$1.25−0.06 (-4.58%)
Close on Oct 19, 2026
- Market cap
- $116.12B
- P/E (TTM)
- –
- Dividend yield
- –
Anavex Life Sciences statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison
Valuation
| Measure | Anavex Life Sciences | Industry median |
|---|---|---|
| Market Cap | $115.87M | $166.30M |
| Enterprise Value | -$2.45M | $88.19M |
| PB Ratio | 1.03 | 2.03 |
| P/TBV Ratio | 1.03 | 2.29 |
Income (trailing twelve months)
| Measure | Anavex Life Sciences | Industry median |
|---|---|---|
| Operating Income | -$17.37M | -$21.40M |
| Net Income | -$13.02M | -$22.46M |
| EBITDA | -$17.37M | -$16.91M |
| EPS (Diluted) | -$0.15 | -$0.83 |
Returns
| Measure | Anavex Life Sciences | Industry median |
|---|---|---|
| Return on Equity (ROE) | -12.8% | -53.2% |
| Return on Assets (ROA) | -11.7% | -40.9% |
Balance sheet
| Measure | Anavex Life Sciences | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $118.33M | $61.43M |
| Net Cash (Debt) | $118.33M | $15.35M |
| Net Cash Per Share | $1.28 | $0.66 |
| Equity (Book Value) | $112.45M | $49.09M |
| Book Value Per Share | $1.21 | $1.37 |
| Tangible Book Value | $112.45M | $23.52M |
Cash flow (trailing twelve months)
| Measure | Anavex Life Sciences | Industry median |
|---|---|---|
| Operating Cash Flow | -$29.29M | -$12.35M |
Efficiency
| Measure | Anavex Life Sciences | Industry median |
|---|---|---|
| Profits Per Employee | -$383.00K | -$703.34K |
| Employee Count | 34 | 74 |
Dividends and yields
| Measure | Anavex Life Sciences | Industry median |
|---|---|---|
| Earnings Yield | -11.2% | -23.3% |
Shares
| Measure | Anavex Life Sciences | Industry median |
|---|---|---|
| Shares Outstanding | 92,696,800 | 58,127,000 |
| Shares Change (YoY) | 8.80% | 10.9% |
| Shares Change (QoQ) | 0.00% | 0.54% |
| Float | 89,752,300 | 49,136,700 |
| Shares Held by Insiders | 3.18% | 11.6% |
| Shares Held by Institutions | 39.9% | 59.4% |
Scores
| Measure | Anavex Life Sciences | Industry median |
|---|---|---|
| Altman Z-Score | 4.07 | -0.22 |
Calculated by StockData from Anavex Life Sciences's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.